Results 81 to 90 of about 391,629 (259)

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

open access: yesMolecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis   +3 more
wiley   +1 more source

Fair use

open access: yesnetbib, 2007
Intellectual property legislation has continuously redefined the balance between the interests of stakeholders, especially the authors of creative works, and the users of the works. The contemporary balance of legal, technical, social, political, and economical interests has typically been formulated into the copyright law stating the limits of the ...
openaire   +3 more sources

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

open access: yesMolecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir   +13 more
wiley   +1 more source

Fair Use

open access: yes, 2008
Zum Ausgleich des Interessenkonfliktes zwischen Urheberrechtsinhaber und Werknutzer haben sich im internationalen Vergleich zwei grundlegend unterschiedliche Regelungstechniken entwickelt. Das eine Modell – dessen prominentester und wirtschaftlich bedeutendster Vertreter die Vereinigten Staaten von Amerika sind – versucht den Interessenausgleich ...
openaire   +2 more sources

Generative AI, Copyright and Emancipation: The Case of Digital Art

open access: yesLaw, Technology and Humans
The emancipatory effect of copyright on the lives of creators has long been hindered by the concentration of rights by powerful entities that can hold creativity hostage through exclusive rights over countless cultural references. Exceptions to copyright
Célia F Matias
doaj   +1 more source

Faire Entscheidung dank Fair use

open access: yes, 2013
Google verletzt nicht die Rechte von Autoren und Verlagen, indem es deren Bücher einscannt und auszugsweise zugänglich macht. Das hat am Donnerstag ein New Yorker Gericht unter Berufung auf die amerikanische Fair-use-Doktrin entschieden. Ein Erfolg für die Informationsfreiheit, der jedoch die Durchsetzbarkeit von Urheberrechten bei neuen ...
openaire   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy